title: Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?
authors.forename: Masamichi
authors.initials: M
authors.lastname: Takano
authors.forename: Masanori
authors.initials: M
authors.lastname: Yamamoto
authors.forename: Shigenobu
authors.initials: S
authors.lastname: Inami
authors.forename: Daisuke
authors.initials: D
authors.lastname: Murakami
authors.forename: Koji
authors.initials: K
authors.lastname: Seimiya
authors.forename: Takayoshi
authors.initials: T
authors.lastname: Ohba
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Seino
authors.forename: Kyoichi
authors.initials: K
authors.lastname: Mizuno
mesh_terms: D000368:Aged; D023903:Coronary Restenosis / Q000175:diagnosis* / Q000209:etiology; D003328:Coronary Thrombosis / Q000175:diagnosis* / Q000209:etiology; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D020123:Sirolimus / Q000008:administration & dosage; D013997:Time Factors; D041623:Tomography, Optical Coherence
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus